New data from NeoDynamics' PULSE study presented at major US breast imaging conference

/PRNewswire/ -- Data from the NeoDynamics' PULSE study with its biopsy device NeoNavia shows a success rate of 96% in very complex and risky axilla biopsies....

Related Keywords

Germany ,Georgia ,United States ,Sweden ,Stockholm ,United Kingdom ,Swedish ,German ,Karolinska Institutet ,Anna Eriksrud ,Marc Thill ,Clinical Development Medical Affairs ,Swedish Medical Technology Company ,Professor Marc Thill ,Imaging Symposium ,Uwe Sch ,Clinical Development ,Medical Affairs ,Neodynamics ,